Seong-Yun Jeong Selected Research

Seong-Yun Jeong Research Topics

Disease

54	Neoplasms (Cancer) 01/2024 - 04/2006
10	Lung Neoplasms (Lung Cancer) 09/2023 - 01/2011
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 05/2010
6	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 04/2008
5	Breast Neoplasms (Breast Cancer) 12/2017 - 11/2012
4	Pancreatic Neoplasms (Pancreatic Cancer) 08/2023 - 02/2016
4	Neoplasm Metastasis (Metastasis) 01/2023 - 05/2010
4	Colonic Neoplasms (Colon Cancer) 01/2023 - 12/2013
4	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 02/2009
4	Stomach Neoplasms (Stomach Cancer) 12/2021 - 10/2017
4	Infections 01/2015 - 07/2010
3	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 04/2012
3	Necrosis 01/2013 - 11/2009
2	Foot-and-Mouth Disease 03/2024 - 02/2024
2	Lymphatic Metastasis 01/2017 - 02/2016
2	Adenocarcinoma of Lung 04/2016 - 02/2015
2	Leukemia 01/2015 - 01/2010
2	Hyperthermia 01/2011 - 05/2009
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Aggressive Fibromatosis (Desmoid) 05/2021
1	Sarcoma (Soft Tissue Sarcoma) 07/2019
1	Cardiotoxicity 01/2018
1	Adenoid Cystic Carcinoma (Cylindroma) 12/2017
1	Alopecia (Baldness) 12/2017
1	Edema (Dropsy) 12/2017
1	Cholangiocarcinoma 06/2017
1	Melanoma (Melanoma, Malignant) 01/2017

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2024 - 02/2009
5	Therapeutic UsesIBA 08/2023 - 06/2012
5	Peptides (Polypeptides)IBA 10/2020 - 11/2009
4	Docetaxel (Taxotere)FDA Link 01/2022 - 11/2016
4	LigandsIBA 01/2017 - 01/2013
3	ErbB Receptors (EGF Receptor)IBA 01/2019 - 09/2013
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 01/2011
3	CaspasesIBA 12/2013 - 11/2012
2	VaccinesIBA 03/2024 - 02/2024
2	AntigensIBA 03/2024 - 02/2024
2	AntibodiesIBA 08/2023 - 08/2023
2	Cytotoxins (Cytolysins)IBA 08/2023 - 01/2015
2	Immunoconjugates (Immunoconjugate)IBA 08/2023 - 12/2021
2	Small Interfering RNA (siRNA)IBA 01/2023 - 09/2019
2	Trastuzumab (Herceptin)FDA Link 12/2021 - 01/2018
2	Fluorouracil (Carac)FDA LinkGeneric 10/2020 - 06/2017
2	Biomarkers (Surrogate Marker)IBA 07/2019 - 06/2017
2	Histone Deacetylase InhibitorsIBA 01/2018 - 04/2012
2	Antineoplastic Agents (Antineoplastics)IBA 12/2017 - 11/2009
2	(5- (4- amino- 6- bromo- 5- carbamoyl- 1H- pyrrolo(2,3- d)pyrimidin- 1- yl)- 3,4- dihydroxytetrahydrofuran- 2- yl)methyl isobutyrateIBA 01/2017 - 08/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 10/2016
2	SurvivinIBA 10/2016 - 01/2013
2	Estrogen ReceptorsIBA 01/2015 - 12/2013
2	1-methylxanthineIBA 05/2009 - 02/2009
2	Caffeine (No Doz)FDA LinkGeneric 05/2009 - 02/2009
1	Synthetic Vaccines (Recombinant Vaccines)IBA 03/2024
1	Combined VaccinesIBA 02/2024
1	Valosin Containing ProteinIBA 01/2024
1	ATPases Associated with Diverse Cellular ActivitiesIBA 01/2024
1	phosphomevalonate kinaseIBA 09/2023
1	Neoplasm Antigens (Tumor Antigens)IBA 08/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	human ERBB2 proteinIBA 12/2021
1	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 10/2020
1	Human Serum Albumin FDA LinkGeneric 10/2020
1	pifithrinIBA 09/2019
1	C-Reactive ProteinIBA 07/2019
1	olaparibIBA 01/2019
1	gambogic acidIBA 01/2019
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019
1	Vorinostat FDA Link 01/2019
1	CrizotinibIBA 01/2019
1	Cycloheximide (Cicloheximide)IBA 01/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Sulfhydryl Compounds (Thiols)IBA 01/2019
1	prolinedithiocarbamate (PDTC)IBA 01/2018
1	Androgen Receptors (Androgen Receptor)IBA 01/2018
1	pyrrolidine dithiocarbamic acidIBA 01/2018
1	chrysinIBA 12/2017
1	Cisplatin (Platino)FDA LinkGeneric 10/2017
1	NanocapsulesIBA 10/2017
1	Peptide LibraryIBA 10/2017
1	Formaldehyde (Formol)FDA Link 06/2017
1	Type 4 Fibroblast Growth Factor ReceptorIBA 06/2017
1	ParaffinIBA 06/2017
1	Bile Acids and Salts (Bile Acids)IBA 06/2017
1	CalpainIBA 01/2017
1	Beclin-1IBA 06/2016
1	Protein Kinases (Protein Kinase)IBA 02/2016
1	tyrosine receptor (receptor, tyrosine)IBA 02/2016

Therapy/Procedure

22	Radiotherapy 09/2023 - 05/2010
16	Therapeutics 01/2024 - 04/2008
3	Drug Therapy (Chemotherapy) 01/2018 - 12/2015
2	Immunotherapy 08/2023 - 03/2020
2	Adjuvant Radiotherapy 10/2020 - 07/2019
1	Bioreactors (Bioreactor) 03/2024
1	Aftercare (After-Treatment) 11/2020
1	Precision Medicine 10/2020
1	Neoadjuvant Therapy 10/2020
1	Intraperitoneal Injections 09/2019
1	Castration 01/2018
1	Operative Surgical Procedures 02/2016